October 22, 2021

Dr. Johns interviewed by Healio

Regenstrief Research Scientist Shelley Johns, PysD, outlined how acceptance and commitment therapy can be beneficial to breast cancer survivors who are dealing with fear of cancer recurrence.

Regenstrief Research Scientist Shelley Johns, PysD, outlined how acceptance and commitment therapy can be beneficial to breast cancer survivors who are dealing with fear of cancer recurrence.

READ THE HEALIO ARTICLE
The Latest
Expanding health equity by including nursing home residents in clinical trials
News

Expanding health equity by including nursing home residents in clinical trials

Regenstrief Institute will host collaborative conference to improve public health data
News

Regenstrief Institute will host collaborative conference to improve public health data

Study reports chlamydia and gonorrhea more likely to be treated per CDC guidelines in males, younger patients and individuals identifying as Black or multiracial
News

Study reports chlamydia and gonorrhea more likely to be treated per CDC guidelines in males, younger patients and individuals identifying as Black or multiracial

Dr. Vachon on how partner satisfaction impacts breast cancer survivors’ well-being
Video

Dr. Vachon on how partner satisfaction impacts breast cancer survivors’ well-being

Call for Papers on Artificial Intelligence Applied to Pediatric Care
Influence

Call for Papers on Artificial Intelligence Applied to Pediatric Care

Dr. Maratt on closing screening gaps for colorectal cancer
Video

Dr. Maratt on closing screening gaps for colorectal cancer